Altered frequency and phenotype of CD4 + forkhead box protein 3 + T cells and its association with autoantibody production in human immunodeficiency virus-infected paediatric patients

Clinical and Experimental Immunology

Volumn 168, Issue 2, 2012, Pages 224-233

  Arguello R J ^a   Balbaryski, J ^b   Barboni, G ^b   Candi, M ^b   Gaddi, E ^b   Laucella, S ^a  

^a Instituto Nacional de Parasitología 'Dr Mario Fatala Chabén'   (Argentina)

^b HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

Author keywords

Autoantibodies; Paediatric HIV; T reg

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA ANTIBODY; IMMUNOGLOBULIN; INTERLEUKIN 7 RECEPTOR; MITOCHONDRION ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; NUCLEAR FACTOR ANTIBODY; RHEUMATOID FACTOR; SMOOTH MUSCLE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERGAMMAGLOBULINEMIA; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PHENOTYPIC VARIATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD;

ADOLESCENT; AUTOANTIBODIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HIV; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; T-LYMPHOCYTES, REGULATORY; VIRAL LOAD;

EID: 84859230753     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2012.04569.x     Document Type: Article

References (59)

1. Adeegbe D, Bayer AL, Levy RB, Malek TR. Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance. J Immunol 2006; 176:7149-53.
2. Chang X, Zheng P, Liu Y. Homeostatic proliferation in the mice with germline Foxp3 mutation and its contribution to fatal autoimmunity. J Immunol 2008; 181:2399-406.
3. Piccirillo CA, D'Hennezel E, Sgouroudis E, Yurchenko E. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas. Curr Opin Immunol 2008; 20:655-62.
4. Kotsianidis I, Bouchliou I, Nakou E etal. Kinetics, function and bone marrow trafficking of CD4+CD25+FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia 2009; 23:510-18.
5. Card CM, McLaren PJ, Wachihi C, Kimani J, Plummer FA, Fowke KR. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J Infect Dis 2009; 199:1318-22.
6. Manigold T, Shin EC, Mizukoshi E etal.Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood 2006; 107:4424-32.
7. Bi X, Suzuki Y, Gatanaga H, Oka S. High frequency and proliferation of CD4+Foxp3+ Treg in HIV-1-infected patients with low CD4 counts. Eur J Immunol 2009; 39:301-9.
8. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004; 78:2454-9.
9. Gavin MA, Torgerson TR, Houston E etal. Single-cell analysis of normal and Foxp3-mutant human T cells:Foxp3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006; 103:6659-64.
10. + Treg cells. J Exp Med 2006; 203:1701-11.
11. Seddiki N, Santner-Nanan B, Martinson J etal. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693-700.
12. Zheng Y, Manzotti CN, Burke F etal. Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not Foxp3. J Immunol 2008; 181:1683-91.
13. Mozos A, Garrido M, Carreras J etal. Redistribution of Foxp3-positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-infected patients. J Acquir Immune Defic Syndr 2007; 46:529-37.
14. Bandera A, Ferrario G, Saresella M etal. CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS ONE 2010; 5:e10788.
15. Gudo ES, Bhatt NB, Bila DR etal. Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS? BMC Infect Dis 2009; 9:211-23.
16. Leligdowicz A, Feldmann J, Jaye A etal. Direct relationship between virus load and systemic immune activation in HIV-2 infection. J Infect Dis 2010; 201:114-22.
17. Lim HW, Hillsamer P, Banham AH, Kim CH. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 2005; 175:4180-3.
18. Moir S, Fauci AS. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol 2008; 122:12-19.
19. De Milito A, Mörch C, Sönnerborg A, Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 2001; 15:957-64.
20. Titanji K, Nilsson A, Mörch C etal. Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection. Clin Exp Immunol 2003; 132:297-303.
21. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002; 1:329-37.
22. Rodriguez C, Stiehm ER, Plaeger-Marshall S. Peripheral B-cell activation and immaturity in HIV-infected children. Ann NY Acad Sci 1993; 693:291-4.
23. Jarvis JN, Taylor H, Iobidze M, Dejonge J, Chang S, Cohen F. Rheumatoid factor expression and complement activation in children congenitally infected with human immunodeficiency virus. Clin Immunol Immunopathol 1993; 67:50-4.
24. González CM, López-Longo FJ, Samson J etal. Antiribonucleoprotein antibodies in children with HIV infection: a comparative study with childhood-onset systemic lupus erythematosus. AIDS Patient Care STDS 1998; 12:21-8.
25. Stricker K, Knipping E, Böhler T, Benner A, Krammer PH, Debatin KM. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children. Cell Death Differ 1998; 5:222-30.
26. Eley BS, Hughes J, Potgieter S, Keraan M, Burgess J, Hussey GD. Immunological manifestations of HIV-infected children. Ann Trop Paediatr 1999; 19:3-7.
27. Shah I, Chudgar P. Antiphospholipid syndrome in a human immunodeficiency virus 1-infected child. Pediatr Infect Dis J 2006; 25:185-6.
28. Legrand FA, Nixon DF, Loo CP etal. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE 2006; 1:e102.
29. Prendergast A, O'Callaghan M, Menson E etal. Factors influencing T cell activation and programmed death 1 expression in HIV-infected children. AIDS Res Hum Retroviruses 2011. [Epub ahead of print].
30. CDC Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morb Mortal Wkly Rep 1994; 43:1-10.
31. Yagi H, Nomura T, Nakamura K etal. Crucial role of Foxp3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16:1643-56.
32. Xing S, Fu J, Zhang Z etal. Increased turnover of Foxp3high regulatory T cells is associated with hyperactivation and disease progression of chronic HIV-1 infection. J Acquir Immune Defic Syndr 2010; 54:455-62.
33. Gaardbo JC, Nielsen SD, Vedel SJ etal. Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy. Clin Exp Immunol 2008; 154:80-6.
34. Montes M, Lewis DE, Sanchez C etal.Foxp3+ regulatory T cells in antiretroviral-naive HIV patients. AIDS 2006; 20:1669-71.
35. Stevenson M. HIV-1 pathogenesis. Nat Med 2003; 9:853-60.
36. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214:231-41.
37. Avcin T, Toplak N. Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep 2007; 9:212-18.
38. Metlas R, Srdic T, Veljkovic V. Anti-IgG antibodies from sera of healthy individuals neutralize HIV-1 primary isolates. Curr HIV Res 2007; 5:261-5.
39. Haynes BF, Nicely NI, Alam SM. HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention? Nat Struct Mol Biol 2010; 17:543-5.
40. Hernandez GT, Critchfield JM, Rodriguez RA. Interpretation of serologic tests in an HIV-infected patient with kidney disease. Nat Clin Pract Nephrol 2006; 2:708-12.
41. Shoenfeld Y, Blank M, Abu-Shakra M etal. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J 2008; 10:13-19.
42. Zelenay S, Lopes-Carvalho T, Caramalho J, Moraes-Fontes MF, Rebelo M, Demengeot J. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci USA 2005; 102:4091-6.
43. Horwitz DA. Identity of mysterious CD4+CD25-Foxp3+ cells in SLE. Arthritis Res Ther 2010; 12:101-3.
44. Nishioka T, Shimizu J, Iida R, Yamazaki S, Sakaguchi S. CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol 2006; 176:6586-93.
45. Sodora D, Silvestri G. Immune activation and AIDS pathogenesis. AIDS 2008; 22:439-46.
46. Eggena MP, Barugahare B, Jones N etal. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005; 174:4407-14.
47. Suen JL, Li HT, Jong YJ, Chiang BL, Yen JH. Altered homeostasis of CD4(+)Foxp3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology 2009; 127:196-205.
48. Yang J, Chu Y, Yang X etal. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009; 60:1472-83.
49. + T cells in patients with systemic lupus erythematosus. J Immunol 2009; 182:1689-95.
50. Moes N, Rieux-Laucat F, Begue B etal. Reduced Expression of Foxp3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 2010; 139:770-8.
51. Fazekas de St Groth B, Landay AL. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? AIDS 2008; 22:671-83.
52. De Milito A, Nilsson A, Titanji K etal. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103:2180-6.
53. Titanji K, De Milito A, Cagigi A etal. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 2006; 108:1580-7.
54. Sampalo A, López-Gómez M, Jiménez-Alonso J, Ortiz F, Samaniego F, Garrido F. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease. Clin Immunol Immunopathol 1993; 66:260-8.
55. + B cells in HIV infection. Clin Exp Immunol 1999; 115:464-71.
56. Redgrave BE, Stone SF, French MA, Krueger R, James IR, Price P. The effect of combination antiretroviral therapy on CD5 B-cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients. HIV Med 2005; 6:307-12.
57. Herbert W, Virgin E, Wherry J, Ahmed R. Redefining chronic viral infection. Cell 2009; 138:30-50.
58. Gaddi E, Laucella S, Balbaryski J etal. Prognostic value of soluble intercellular adhesion molecule-1 (s-ICAM-1) in HIV-infected children. Scand J Immunol 2000; 52:628-33.
59. Gaddi E, Quiroz H, Balbaryski J etal. L-selectin expression on T lymphocytes and neutrophils in HIV infected children. Medicina (Buenos Aires) 2005; 65:131-7.